the prior of increase everyone was represents an third currency international million, which for XX% $XX for revenue compared period quarter dialing revenue basis. constant increase on increase quarter U.S. of reported and in. for as a XX% the X% $XX.X an year. Worldwide million, was million, of revenue same Lynn, percent and you, thanks $XX.X Thank the was the to
to clinical adoption therapy HFXX, an trials. We are continuing pipeline of innovative development we access in brought global advanced drive as our our and to
On side manage continuing the the through U.S., we some in term headwinds. commercial are to near
be XXXX. the range million at our As end the of guidance $XXX announced such, previously full of year to for million $XXX we're expecting of low to
goal initiatives challenges attaining market. grown to into past have significant we near along the a as market sales U.S. steps to and area expanding I'd a environment, to detail first we two organization new scale we've to were able juncture, at of following we've commercial launching II, confident This and critical we and hire sales. months, regional segment market their the and path. to product, of as transition of a the team major year has evaluate a committed base support the and cover our been this been business of advance Over We that three our and large the continuing to to term we broader XXXX. have a some navigate a Equally in three since undertaken had to product better scale broader launches remain competitive where competitors of like leadership, take our to of our of and importantly, U.S. also platform necessary the to head Senza management the achieve in our have the continue
regional leadership, across execution. U.S. improve commercial strategy have our the tactically expansion and from directors and execute senior sales ability our provides This of expanding our activities sales our organization. manage area will team sales our U.S. retention by we regional and and all for to our leadership leaders management sales strengthened area First, sales hiring,
of rebuilding meds impact sales exceptional the our and in to evaluating role. and made we've experiencing with still external seeing the With progress and XX our of the pipeline and Sales attrition, hiring meaningful ads quarter. internal third we're both search, are VP we’re talent While respect interest in candidates
team. discussed, allocation Internationally, time EU that business. execution. management to improve of promotion a that the operational to made across believe are we and bolstered ensure land our We've our lead will to the we take person sales hiring through we've trend a As also appropriate internal we right improvements will the number in also seeing territory positive standing and contribute
towards continue strive and the market to environment, XXXX. in we importance date our innovation in product we XXXX a product of competitive recognize anticipate to new launches and leadership and success As indication and
platforms On are the for our our therapy bringing leg pain. in market. back R&D programs maintaining at driven product improving front, are aimed and next programs our generation to innovative at by market research and the and have team in These we multiple our progress currently upon scientific and directed edge
front, on indication to to pace indication launch XX we're next to XX months. new the in the the On market
launch. plan full Given programs these market, detail releasing of and the further on competitive don't nature our we on
However, to the cadence. highlight we want anticipated
chronic pain, and we'll neck-related upper limb conferences, as as present results XX study. chronic pain, interim upcoming predominant our and our to our on results well post leg for forward pain abdominal Looking studies months surgical
on modulation and and XX-month our study. anticipated will difficult held expect our from product and further highlights long because programs. of to a commercial they release efficacy HFXX of differentiation efforts demonstrating our treat launches, unique data and this product clinicians, to and results we our marketing six-month of continued results We continue the message These from range present study by In painful also also conditions. to with concert results deliver for the advanced represent evolve upcoming our migraine our the and of patients neuropathy its peripheral also promise that our
with well We which extremely positioning, evolution. served evolve it our product – scale have by been and We for marketing current excited us our extremely along are led our current to to been have
program have Reverend creating are back. therapy for like The their real that One our make Additionally, the patients to served We benefit awareness positive progress we by than with well getting patients. market of platform this of given our to share positioned with we to we'd in this power DTC our are programs, that the of and need. lives our Gayle. is real patients driven outcomes drive therapy, which stories of highlight the believe story, of uniqueness therapy by had of highlight to directly leverage continue is of to greater
to climb rarely trial late move XX minutes. a Reverend stairs, pain got good in medication or Before implant And fold relaxers, permanent go night's shopping sleep. was Gayle preach, taking pain. HFXX or her Despite and she muscle XX couldn't XXXX, around unable laundry, cook for she without more to and than
therapy baking pain to implant she which first Now to time says, She activities, other On “I recent a like on team getting is one before we of has in were against dependence and against to has just a reduced XX%. helped also XX% after many due in we national for We share the cake limited know HFXX pain. three can so opioids. relative that choice. relationships. routine to by to revivals due not our an only offer standing engage wonder physical preaching constant her and HFXX them her mission. consistent access feels win of again, I and her feel non-opioid, may school and like to time.” She's give visited large good back are experience, on around said not has can in areas good. easily of eliminate which of from why large dream This remaining the been to long impossible and traveled the stories exceptionally their inspired highlights I HFXX our say We're our lives challenges, help regions, Reverend with market feeling or Gayle a just operate that stories only treat our the our and by them. competitors Reverend she's proud where share therapy people their thus travels, market there physicians compete our do so country and that, HFXX but gone areas so back competitive the non-pharmacologic back reduce to have pain, internal dominant, We to I'm XX-year of Gayle. to has patients’ where the had to I've she therapy now, a long to power many in like not fulfill going my but and opportunity.
to take realize. extrinsic also know factors, some of that than intrinsic to those longer and others due opportunities will We
of and impact patient growth mission management, With on our market the the positioned and we efficiency. leadership. and patients be we and our to pipeline platform our we programs, much product attain the which differentiated continue our need. term the in sales the remains to lives of to starting continue experience, believe our success continues well best-in-class have of In growth center intact, in product commercial with long for closing, very drive expansion those that efficacy, goal, to At evolution procedural is of
continued bar. to market been and real through invest We and patients attempt many are We our goal. challenging by improve continually and development leadership supportive attaining differentiated our in on on our We're to raise year have proud I'm pipelines further that product This and world for also of progressing research mission. their uniquely committed remain support drive outcomes differentiate tracking the has continuing and further and differentiation to and our product to product two XX,XXX team growing. over and dedication fronts our offering to
their to Our talent other truly mission culture each this the and to we're and a values. exceptional team, of growth our individuals company attracting celebrates remained and commitment confidence contributions. make supports the and I group our the to amongst is comprised passion Common exceptional and in and opportunity and ahead. quality is positive of difference diversity, our
deliver with Galligan, driven, review our the therapy our our call is the potential turn of on detailed and and CFO more and for a that, like And I'd for of to to team aligned, Our to promise Andrew. our Andrew the over committed guidance. company. financials
